Skip to main content

Peer Review reports

From: Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda

Original Submission
10 May 2021 Submitted Original manuscript
20 Jun 2021 Reviewed Reviewer Report
22 Sep 2021 Reviewed Reviewer Report - Francesco Di Gennaro
12 Oct 2021 Author responded Author comments - Adelline Twimukye
21 Oct 2021 Author responded Author comments - Adelline Twimukye
Resubmission - Version 2
12 Oct 2021 Submitted Manuscript version 2
22 Oct 2021 Author responded Author comments - Adelline Twimukye
Resubmission - Version 3
22 Oct 2021 Submitted Manuscript version 3
25 Oct 2021 Author responded Author comments - Adelline Twimukye
Resubmission - Version 4
25 Oct 2021 Submitted Manuscript version 4
27 Oct 2021 Author responded Author comments - Adelline Twimukye
Resubmission - Version 5
27 Oct 2021 Submitted Manuscript version 5
Publishing
9 Nov 2021 Editorially accepted
13 Nov 2021 Article published 10.1186/s12879-021-06851-9

You can find further information about peer review here.

Back to article page